Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Fibrolamellar hepatocellular carcinoma: current clinical perspectives.

Lafaro KJ, Pawlik TM.

J Hepatocell Carcinoma. 2015 Oct 9;2:151-7. doi: 10.2147/JHC.S75153. Review.

2.

Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.

Sergi CM.

Diagnostics (Basel). 2015 Dec 30;6(1). pii: E3. doi: 10.3390/diagnostics6010003.

3.

Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases.

Chagas AL, Kikuchi L, Herman P, Alencar RS, Tani CM, Diniz MA, Pugliese V, Rocha Mde S, D'Albuquerque LA, Carrilho FJ, Alves VA.

Clinics (Sao Paulo). 2015 Mar;70(3):207-13. doi: 10.6061/clinics/2015(03)10.

4.

Case 1-2011: a 26 year-old man with right lower limb edema and liver mass.

Taslimi R, Malekzadeh R, Rahmani M, Azmodeh Ardalan F.

Middle East J Dig Dis. 2011 Mar;3(1):62-71. No abstract available.

5.

Genomic analysis of fibrolamellar hepatocellular carcinoma.

Xu L, Hazard FK, Zmoos AF, Jahchan N, Chaib H, Garfin PM, Rangaswami A, Snyder MP, Sage J.

Hum Mol Genet. 2015 Jan 1;24(1):50-63. doi: 10.1093/hmg/ddu418.

6.

Downstaging and resection after neoadjuvant therapy for fibrolamellar hepatocellular carcinoma.

Fonseca GM, Varella AD, Coelho FF, Abe ES, Dumarco RB, Herman P.

World J Gastrointest Surg. 2014 Jun 27;6(6):107-11. doi: 10.4240/wjgs.v6.i6.107.

7.

Fibrolamellar carcinoma: 2012 update.

Torbenson M.

Scientifica (Cairo). 2012;2012:743790. doi: 10.6064/2012/743790. Review.

8.

Radiotherapy for metastatic fibrolamellar hepatocellular carcinoma.

G Peacock J, A Call J, R Olivier K.

Rare Tumors. 2013 Jul 9;5(3):e28. doi: 10.4081/rt.2013.e28.

9.

Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.

Kaseb AO, Shama M, Sahin IH, Nooka A, Hassabo HM, Vauthey JN, Aloia T, Abbruzzese JL, Subbiah IM, Janku F, Curley S, Hassan MM.

Oncology. 2013;85(4):197-203. doi: 10.1159/000354698.

10.

Imaging of multifocal liver lesions in children and adolescents.

Hegde SV, Dillman JR, Lopez MJ, Strouse PJ.

Cancer Imaging. 2013 Feb 8;12:516-29. doi: 10.1102/1470-7330.2012.0045. Review.

11.

Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A; OLT for HCC Consensus Group..

Lancet Oncol. 2012 Jan;13(1):e11-22. doi: 10.1016/S1470-2045(11)70175-9.

12.

Molecular pathology of hepatic neoplasms: classification and clinical significance.

Walther Z, Jain D.

Patholog Res Int. 2011 Apr 7;2011:403929. doi: 10.4061/2011/403929.

13.

Cell cycle biology of fibrolamellar hepatocellular carcinoma.

Dhingra S, Li W, Tan D, Zenali M, Zhang H, Brown RE.

Int J Clin Exp Pathol. 2010 Nov 2;3(8):792-7.

14.

Lung mass in a 28-year-old male: a case report of a rare tumor.

Mroz RM, Korniluk M, Swidzinska E, Dzieciol J, Czaban J, Panek B, Chyczewska E.

Eur J Med Res. 2010 Nov 4;15 Suppl 2:95-7.

15.

Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver.

Tränkenschuh W, Puls F, Christgen M, Albat C, Heim A, Poczkaj J, Fleming P, Kreipe H, Lehmann U.

PLoS One. 2010 Oct 29;5(10):e13688. doi: 10.1371/journal.pone.0013688.

Items per page

Supplemental Content

Support Center